MiNK Therapeutics Presents Clinical Evidence That a Single, Off-the-Shelf, iNKT Cell Product Drives Context-Dependent Immune Responses at ASGCT 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. MU
5. GOOGL
6. APGE
7. DFTX
8. LCO
9. KR
10. MSTR

Go back to MiNK Therapeutics Presents Clinical Evidence That a Single, Off-the-Shelf, iNKT Cell Product Drives Context-Dependent Immune Responses at ASGCT 2026
(NASDAQ: INKT) Delayed: 12.46 +0.32 (2.64%)
Previous Close $12.14    52 Week High $ 
Open $12.33    52 Week Low $ 
Day High $12.51    P/E N/A 
Day Low $12.01    EPS $ 
Volume 13,602